OC
Oarsman Capital’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.63M | Sell |
23,329
-376
| -2% | -$26.3K | 0.26% | 77 |
|
|
2025
Q1 | $1.74M | Buy |
23,705
+3,726
| +19% | +$274K | 0.31% | 68 |
|
|
2024
Q4 | $1.31M | Sell |
19,979
-1,151
| -5% | -$75.4K | 0.23% | 83 |
|
|
2024
Q3 | $1.65M | Buy |
21,130
+3,142
| +17% | +$245K | 0.3% | 69 |
|
|
2024
Q2 | $1.4M | Buy |
17,988
+3,944
| +28% | +$308K | 0.31% | 70 |
|
|
2024
Q1 | $951K | Sell |
14,044
-1,431
| -9% | -$97K | 0.23% | 92 |
|
|
2023
Q4 | $1.04M | Buy |
15,475
+374
| +2% | +$25.2K | 0.28% | 85 |
|
|
2023
Q3 | $1.02M | Buy |
15,101
+54
| +0.4% | +$3.66K | 0.43% | 64 |
|
|
2023
Q2 | $1.08M | Sell |
15,047
-78
| -0.5% | -$5.58K | 0.47% | 58 |
|
|
2023
Q1 | $1.05M | Buy |
15,125
+1,345
| +10% | +$93.4K | 0.49% | 55 |
|
|
2022
Q4 | $934K | Sell |
13,780
-3,360
| -20% | -$228K | 0.48% | 61 |
|
|
2022
Q3 | $940K | Sell |
17,140
-250
| -1% | -$13.7K | 0.5% | 57 |
|
|
2022
Q2 | $1.15M | Sell |
17,390
-380
| -2% | -$25.1K | 0.57% | 53 |
|
|
2022
Q1 | $1.18M | Buy |
17,770
+625
| +4% | +$41.5K | 0.46% | 65 |
|
|
2021
Q4 | $999K | Buy |
17,145
+145
| +0.9% | +$8.45K | 0.39% | 79 |
|
|
2021
Q3 | $1.02M | Sell |
17,000
-15
| -0.1% | -$901 | 0.41% | 78 |
|
|
2021
Q2 | $1.02M | Buy |
+17,015
| New | +$1.02M | 0.4% | 80 |
|